指南与共识乳腺乳腺X线MRUS

美国放射学会适宜性标准:乳腺癌筛查

ACR Appropriateness Criteria Breast Cancer Screening.
PubMed 文献 · J Am Coll Radiol · 2016-01-01

美国放射学会(ACR)适宜性标准指出,乳腺X线摄影是普通人群乳腺癌筛查的推荐方法;高危女性中,单纯乳腺X线摄影效果不如联合补充筛查,因此推荐对特定高危人群补充MRI或超声筛查;对于中危女性,近期文献支持部分使用乳腺MRI,致密乳腺的中危女性超声可能是一种选择;证据不足以支持热成像、乳腺专用γ成像、正电子发射乳腺摄影和光学成像等其他方式用于筛查。

要点

  • 普通人群乳腺癌筛查推荐乳腺X线摄影。
  • 高危女性推荐补充MRI或超声筛查,不能接受MRI的高危女性超声是选项。
  • 证据不足以支持热成像、乳腺专用γ成像、正电子发射乳腺摄影和光学成像用于筛查。

核心结论

  • 乳腺X线摄影是普通人群乳腺癌筛查的推荐方法;高危女性推荐补充MRI或超声筛查,不能接受MRI的高危女性超声是选项;中危女性可考虑乳腺MRI,致密乳腺的中危女性超声可能是一种选择;证据不足以支持热成像、乳腺专用γ成像、正电子发射乳腺摄影和光学成像用于筛查。

研究设计与样本

  • 美国放射学会(ACR)适宜性标准,基于证据的指南,由多学科专家小组每2年审查一次,制定和审查包括对同行评议期刊当前医学文献的广泛分析,并应用改良德尔菲共识方法对影像和治疗程序的适宜性进行评级;证据缺乏或不明确时,可使用专家意见推荐影像或治疗。

诊断标准与关键数值

  • 普通人群乳腺癌筛查推荐乳腺X线摄影。
  • 高危女性推荐补充MRI或超声筛查;不能接受MRI的高危女性超声是选项。
  • 中危女性可考虑乳腺MRI;致密乳腺的中危女性超声可能是一种选择。
  • 证据不足以支持热成像、乳腺专用γ成像、正电子发射乳腺摄影和光学成像用于乳腺癌筛查。

临床应用与阅片要点

  • 普通人群乳腺癌筛查推荐乳腺X线摄影。
  • 高危女性推荐补充MRI或超声筛查;不能接受MRI的高危女性超声是选项。
  • 中危女性可考虑乳腺MRI;致密乳腺的中危女性超声可能是一种选择。
  • 证据不足以支持热成像、乳腺专用γ成像、正电子发射乳腺摄影和光学成像用于乳腺癌筛查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Mammography is the recommended method for breast cancer screening of women in the general population. However, mammography alone does not perform as well as mammography plus supplemental screening in high-risk women. Therefore, supplemental screening with MRI or ultrasound is recommended in selected high-risk populations. Screening breast MRI is recommended in women at high risk for breast cancer on the basis of family history or genetic predisposition. Ultrasound is an option for those high-risk women who cannot undergo MRI. Recent literature also supports the use of breast MRI in some women of intermediate risk, and ultrasound may be an option for intermediate-risk women with dense breasts. There is insufficient evidence to support the use of other imaging modalities, such as thermography, breast-specific gamma imaging, positron emission mammography, and optical imaging, for breast cancer screening. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review includes an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Mainiero MB, Lourenco A, Mahoney MC, et al. ACR Appropriateness Criteria Breast Cancer Screening. J Am Coll Radiol. 2016. PMID: 27814813. doi:10.1016/j.jacr.2016.09.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。